IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and a world leading provider of proton therapy solutions for the treatment of cancer, has announced it has signed a total system restoration contract with Massachusetts General Hospital, which was IBA’s first-ever proton therapy installation. The total value of the contract is between US$80 and US$100 million.
Latham & Watkins LLP advised Massachusetts General Hospital in the transaction with a healthcare and life sciences team led by Washington, D.C. partner Jason B. Caron, with associates Yanyan Zhou, Chad Leiper, and Danny Machado. Advice was also provided on FDA regulatory matters by Washington, D.C. partner Ben Haas; and on data and technology transaction matters by Bay Area partner Tony Klein, with associate Debbie Hinck.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
